Pinned straw:
CSI Frankfurt
It’s a conference organised by the CSI (Congenital, Structural, and Valvular Heart Disease Interventions) Congress.
It looks like there was a live presentation yesterday in DurAVR by another TAVR heavy-hitter, Professor Ole De Backer. Anteris is gaining some broad traction in the credibility game.
I think news is afoot. Prof Ole De Backer has a pretty full schedule this coming week at the New York Valves Symposium :
https://www.nyvalvesconference.com/program-guide?sessionType=session-16122&sessionType=session-16794
To top it off there is more focus on improved cardiac imaging. Dr Rebecca Hahn is a Program Leader at New York Valves 2025. She has at least been on Anteris’ Scientific Advisory Board previously, but there is no mention of it here:
https://www.nyvalvesconference.com/faculty/Rebecca-Hahn-2232
I’m hoping it means she is still involved just not in a paid capacity at this stage? I don’t know.
This is her bio:
https://doctors.columbia.edu/us/ny/new-york/rebecca-t-hahn-md-161-fort-washington-avenue
In the 2022 AGM Anteris played an interview of a very excited Dr Hahn talking about the haemodynamics of DurAVR. I can’t find that video anywhere atm. Here is a later recorded quote from her but:
So no mention of Anteris at all yet— and only one small mention of DurAVR for Prof De Backer’s presentation — but I see it’s (or at least I’m jumping at) shadow(s). It feels like Anteris has been unusually quiet with a lack of updates, it’d be great to hear some timeframes/good news about the PARADIGM trial commencing.
I’ll own it. That was a bad hot take. There wasn’t actual news. There was a tweet at the end of the week that Anteris had booked a big room in New York City, invited a bunch of people, and then fed them. Myself and the market are looking for a big ol’ serving of some tasty IDE but and we got X — and nothing to actually digest.
I’ve zoomed in to the photos, no dinner plates thankfully. Probably just canapés. Hopefully everyone paid for their own wine. I am abstaining from my like at this point in time. That is all. Thank you.
